Concepedia

Author

S A Rosenberg

National Institutes of Health

Also Known As

Rosenberg, Steven A., S A ROSENBERG, S A Rosenberg, S. A. Rosenberg, S. Rosenberg, S.A. Rosenberg, Shapir Rosenberg, Steven A. Rosenberg

169

Publications

20.2K

Citations

71

H-Index

136

Concepts

All Affiliations

National Institutes of HealthNational Cancer InstituteNational Cancer InstituteNational Institutes of Health Clinical Center
SA

About

S A Rosenberg is an author at National Institutes of Health specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

48

74

10.3K

2

Health Sciences

6

6

762

3

Education

1

1

14

4

Engineering

1

1

1.6K

5

Language Studies

1

1

14

S A Rosenberg

×

111

Publications

19.1K

Citations

69

H-Index

YearCitations

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

Tim Lister, D. Crowther, S.B. Sutcliffe,

Journal of Clinical Oncology

1989

1.6K

Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.

Jin Yang, Alfred E. Chang, A Baker,

Journal of Clinical Oncology

1998

1.5K

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

G. Fyfe, Richard I. Fisher, S A Rosenberg,

Journal of Clinical Oncology

1995

1.4K

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.

Yutaka Kawakami, S Eliyahu, Kazuyasu Sakaguchi,

The Journal of Experimental Medicine

1994

854

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

S A Rosenberg, James J. Mulé, Paul J. Spiess,

The Journal of Experimental Medicine

1985

740

Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced Cancer

S A Rosenberg, Michael T. Lotze, Jin‐Hao Yang,

JNCI Journal of the National Cancer Institute

1993

639

Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy

Nicholas P. Restifo, Franco Marincola, Yutaka Kawakami,

JNCI Journal of the National Cancer Institute

1996

528

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas.

Suzanne L. Topalian, D. Solomon, S A Rosenberg

The Journal of Immunology

1989

515

Biologic Therapy of Cancer

Robin P Reid, V. T. DeVita, S Hellman,

Histopathology

1992

474

Patterns of recurrence in patients with high-grade soft-tissue sarcomas.

David A. Potter, Jerry Glenn, Timothy J. Kinsella,

Journal of Clinical Oncology

1985

377

Page 1